Corticeira Amorim Splits Its US Closures Arm 50/50 With Scott Laboratories — Joint Venture Scott Premium Closures Absorbs ACIC Cork & Closures for the North American Wine and Spirits Market

Corticeira Amorim — the Mozelos, Santa Maria da Feira-headquartered group that anchors the world’s cork value chain — has signed a 50/50 joint venture with the North American specialty supplier Scott Laboratories, folding the two parties’ separate US closures operations into a single independent vehicle named Scott Premium Closures. The arrangement was first reported by Jornal de Negócios and confirmed via Corticeira Amorim’s Q1 2026 relatório e contas (report and accounts) filing, and it targets the cork stoppers used by the wine and spirits (bebidas espirituosas) industry across the United States and Canada.

The mechanics are clean. Scott Laboratories has transferred all of its cork sales, technical support and operations into Scott Premium Closures. Corticeira Amorim, on the other side of the deal, has transferred ACIC Cork & Closures — its existing US subsidiary in the closures space — into the same vehicle. The capital then sits 50/50 between the two shareholders, and the JV stands as an independent legal entity rather than as a branded outpost of either parent. Corticeira Amorim flagged the move in its Q1 2026 accounts as a passo "estratégico" (strategic step) toward "estabilidade de fornecimento a longo prazo e à independência operacional" (long-term supply stability and operational independence), per the filing.

The Sales Number on the Table

Corticeira Amorim has estimated the impact of the Scott Premium Closures vehicle on its 2026 group sales at €15 million. That figure is a Corticeira-reported impact line, not the JV’s total revenue, and reflects only the slice that flows back to the Portuguese parent under the 50/50 architecture. The €15 million sits inside a group consolidated revenue base that ran past €1 billion in 2024 — meaningful for the closures division’s US-and-Canada slice, modest at the group level.

Why North America, Why Now

The US still-wine market is where natural cork stoppers have lost the most share over the past two decades, with aluminum screw-caps (Stelvin-type) and synthetic stoppers carving out the under-USD-25 tier and parts of the premium tier. Corticeira Amorim’s response over the same period has been a vertical-integration playbook: own the cork forest (Amorim Florestal), own the production (Amorim Cork), and own the in-market sales-and-service footprint — which is where the ACIC Cork & Closures piece fits in. The new JV adds Scott Laboratories’ technical-services book and existing winery customer base to that footprint, taking the cork-side product into a single sales-and-support stack rather than two competing ones.

The spirits component is the second leg. Stoppers for whiskey, rum, tequila and the rising US craft-spirits category are a higher-margin sub-category than mass-market still-wine closures, and Scott Laboratories has long-standing relationships across that book. Folding cork stoppers into a single channel positions Corticeira Amorim to push the natural-cork product specifically into the spirits-premiumisation cycle that the US distilled-spirits trade has been running through.

Where the Scott Premium Closures Vehicle Sits in the Corticeira Map

Corticeira Amorim runs five business units — Amorim Cork (rolhas, stoppers), Amorim Cork Composites, Amorim Cork Flooring, Amorim Cork Insulation and Amorim Cork Solutions — alongside Amorim Florestal on the upstream forest side. Closures (rolhas) is the single biggest revenue line, and within that line the US and Canada are the largest single export market on a country-pair basis. The Scott Premium Closures vehicle therefore sits as the new commercial face of Amorim Cork in the geography where it sells the most stoppers and where it has lost the most share-of-cap.

The structural choice — a 50/50 JV rather than a wholly-owned subsidiary — also matters. It locks in Scott Laboratories’ pre-existing winery and distillery relationships as JV equity rather than as a thin distribution agreement, and it shares the commercial risk on the cork-vs-screwcap battle that the JV will continue to fight in the US tier-one and tier-two markets.

The Listing Angle on Euronext Lisbon

Corticeira Amorim is listed on Euronext Lisbon under ticker CORA. The Q1 2026 accounts that disclosed the JV are the first formal venue for the deal’s financial footprint. Equity analysts covering the stock will read the €15 million estimated sales impact against the consolidated revenue line, but the structural read is on margin — the Scott Premium Closures vehicle should let the closures division consolidate sales-and-support spend in the geography, with margin expansion ahead of the revenue line if the integration runs to plan.

What This Means for Expats and Residents

• The Portuguese cork industry is mid-restructuring: The Scott Premium Closures JV lands alongside the broader Corticeira Amorim cost-and-headcount reset reported earlier this quarter. Expect more US-market consolidation moves through the rest of 2026.
• The CORA stock has a fresh data point: Q1 2026 filings now formally disclose the JV. Investors holding Portuguese equities through PSI-tracking funds will see the impact through the broader Amorim Cork closures line rather than as a standalone segment.
• Cork as an export category remains policy-relevant: Portugal supplies more than half of global cork production. The US-and-Canada commercial setup is downstream of the Alentejo, Algarve and Ribatejo cork-oak (sobreiro) forest base, which is itself protected under the Decreto-Lei nº 169/2001 on cork-oak and holm-oak conservation. Forest-side stability is the upstream guarantee for the JV’s product pipeline.
• The spirits push is the part to watch: The US craft-distilling cycle is in expansion. The new JV is positioned to scale the natural-cork product into the spirits-premiumisation lane, where the margin headroom is wider than in still wines.

The Scott Premium Closures vehicle now operates as an independent JV across the United States and Canada. Corticeira Amorim retains 50% of the equity; Scott Laboratories holds the other 50%. The first integrated commercial year runs through the 2026 calendar.